文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

外源性烟酰胺腺嘌呤二核苷酸改善大鼠心脏骤停后复苏后心肌与神经功能

Exogenous Nicotinamide Adenine Dinucleotide Attenuates Postresuscitation Myocardial and Neurologic Dysfunction in a Rat Model of Cardiac Arrest.
PubMed 文献 · Crit Care Med · 2022-01-01
一句话结论大鼠心脏骤停模型中,复苏即刻静脉给予NAD+ 20 mg/kg可改善复苏后血流动力学、心功能、神经功能评分与生存率。

NAD组在自主循环恢复即刻静脉注射烟酰胺腺嘌呤二核苷酸20 mg/kg。结果显示NAD治疗改善了复苏后1小时平均动脉压和射血分数、24小时神经功能缺损评分及生存率,并恢复脑和心肌ATP水平与线粒体复合物I呼吸功能,机制涉及Sirtuin3-NDUFA9去乙酰化。

要点

  • 在6分钟心室颤动后心肺复苏的大鼠中,自主循环恢复即刻静脉给予NAD+ 20 mg/kg,1小时平均动脉压为94.69±4.25 mmHg,高于对照组的89.57±7.71 mmHg(p<0.05)。
  • 同一模型中,NAD组复苏后1小时射血分数为62.67%±6.71%,高于对照组的52.96%±9.37%(p<0.05)。
  • NAD组复苏后24小时神经功能缺损评分为449.50±82.58,高于对照组的339.50±90.66(p<0.05),并改善生存率。
  • NAD治疗恢复了脑和心肌组织的ATP水平及线粒体复合物I呼吸功能,并激活Sirtuin3通路、下调乙酰化NDUFA9。
  • 该证据来自大鼠模型,NAD+ 20 mg/kg静脉给药方案不能直接外推为临床推荐剂量。

适用人群与场景

  • 研究人群为Sprague-Dawley大鼠,非临床患者;模型为6分钟未处理心室颤动后行心肺复苏。
  • 原文未提及临床纳入或排除人群,也未说明急诊、ICU或院前适用场景。

诊断标准与关键阈值

  • 原文未提及

处置流程与药物剂量

  • 在自主循环恢复即刻静脉给予烟酰胺腺嘌呤二核苷酸+ 20 mg/kg;该剂量为大鼠实验方案,非临床推荐剂量。

红旗征与不能漏的情况

  • 原文未提及

研究设计与关键结果

  • 与对照组相比,NAD组复苏后1小时平均动脉压(94.69±4.25 mmHg vs 89.57±7.71 mmHg,p<0.05)和射血分数(62.67%±6.71% vs 52.96%±9.37%,p<0.05)改善。
  • NAD组复苏后24小时神经功能缺损评分优于对照组(449.50±82.58 vs 339.50±90.66,p<0.05),生存率改善。
  • NAD组脑和心肌ATP水平及复合物I呼吸功能显著恢复,并激活Sirtuin3通路、下调乙酰化NDUFA9。

证据类型、等级与局限

  • 证据类型为动物实验(大鼠模型),原文未给出证据等级或推荐强度。

对床旁实践的改变

  • 该内容提示NAD+在心脏骤停复苏后可能通过保护线粒体复合物I呼吸和ATP生成减轻心肌与神经功能障碍,但仅限大鼠模型,尚不能改变急诊或ICU临床实践。
  • 适用与不适用人群原文未提及;常见陷阱是将动物实验剂量20 mg/kg静脉给药直接当作临床推荐剂量。

指南或共识出处

  • 原文未提及

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the therapeutic potential and underlying mechanisms of exogenous nicotinamide adenine dinucleotide+ on postresuscitation myocardial and neurologic dysfunction in a rat model of cardiac arrest.

DESIGN: Thirty-eight rats were randomized into three groups: 1) Sham, 2) Control, and 3) NAD. Except for the sham group, untreated ventricular fibrillation for 6 minutes followed by cardiopulmonary resuscitation was performed in the control and NAD groups. Nicotinamide adenine dinucleotide+ (20 mg/kg) was IV administered at the onset of return of spontaneous circulation.

SETTING: University-affiliated research laboratory.

SUBJECTS: Sprague-Dawley rats.

INTERVENTIONS: Nicotinamide adenine dinucleotide+.

MEASUREMENTS AND MAIN RESULTS: Hemodynamic and myocardial function were measured at baseline and within 4 hours following return of spontaneous circulation. Survival analysis and Neurologic Deficit Score were performed up to 72 hours after return of spontaneous circulation. Adenosine triphosphate (adenosine triphosphate) level was measured in both brain and heart tissue. Mitochondrial respiratory chain function, acetylation level, and expression of Sirtuin3 and NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9 (NDUFA9) in isolated mitochondrial protein from both brain and heart tissue were evaluated at 4 hours following return of spontaneous circulation. The results demonstrated that nicotinamide adenine dinucleotide+ treatment improved mean arterial pressure (at 1 hr following return of spontaneous circulation, 94.69 ± 4.25 mm Hg vs 89.57 ± 7.71 mm Hg; p < 0.05), ejection fraction (at 1 hr following return of spontaneous circulation, 62.67% ± 6.71% vs 52.96% ± 9.37%; p < 0.05), Neurologic Deficit Score (at 24 hr following return of spontaneous circulation, 449.50 ± 82.58 vs 339.50 ± 90.66; p < 0.05), and survival rate compared with that of the control group. The adenosine triphosphate level and complex I respiratory were significantly restored in the NAD group compared with those of the control group. In addition, nicotinamide adenine dinucleotide+ treatment activated the Sirtuin3 pathway, down-regulating acetylated-NDUFA9 in the isolated mitochondria protein.

CONCLUSIONS: Exogenous nicotinamide adenine dinucleotide+ treatment attenuated postresuscitation myocardial and neurologic dysfunction. The responsible mechanisms may involve the preservation of mitochondrial complex I respiratory capacity and adenosine triphosphate production, which involves the Sirtuin3-NDUFA9 deacetylation.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Su C, Xiao Y, Zhang G, et al. Exogenous Nicotinamide Adenine Dinucleotide Attenuates Postresuscitation Myocardial and Neurologic Dysfunction in a Rat Model of Cardiac Arrest. Crit Care Med. 2022. PMID: 34637412. doi:10.1097/CCM.0000000000005268

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。